School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
Melbourne Medical School, University of Melbourne, Parkville, Victoria, Australia.
JAMA Netw Open. 2019 Aug 2;2(8):e198398. doi: 10.1001/jamanetworkopen.2019.8398.
Frailty is a common geriatric syndrome of significant public health importance, yet there is limited understanding of the risk of frailty development at a population level.
To estimate the global incidence of frailty and prefrailty among community-dwelling adults 60 years or older.
MEDLINE, Embase, PsycINFO, Web of Science, CINAHL Plus, and AMED (Allied and Complementary Medicine Database) were searched from inception to January 2019 without language restrictions using combinations of the keywords frailty, older adults, and incidence. The reference lists of eligible studies were hand searched.
In the systematic review, 2 authors undertook the search, article screening, and study selection. Cohort studies that reported or had sufficient data to compute incidence of frailty or prefrailty among community-dwelling adults 60 years or older at baseline were eligible.
The methodological quality of included studies was assessed using The Joanna Briggs Institute's Critical Appraisal Checklist for Prevalence and Incidence Studies. Meta-analysis was conducted using a random-effects (DerSimonian and Laird) model.
Incidence of frailty (defined as new cases of frailty among robust or prefrail individuals) and incidence of prefrailty (defined as new cases of prefrailty among robust individuals), both over a specified duration.
Of 15 176 retrieved references, 46 observational studies involving 120 805 nonfrail (robust or prefrail) participants from 28 countries were included in this systematic review. Among the nonfrail individuals who survived a median follow-up of 3.0 (range, 1.0-11.7) years, 13.6% (13 678 of 100 313) became frail, with the pooled incidence rate being 43.4 (95% CI, 37.3-50.4; I2 = 98.5%) cases per 1000 person-years. The incidence of frailty was significantly higher in prefrail individuals than robust individuals (pooled incidence rates, 62.7 [95% CI, 49.2-79.8; I2 = 97.8%] vs 12.0 [95% CI, 8.2-17.5; I2 = 94.9%] cases per 1000 person-years, respectively; P for difference < .001). Among robust individuals in 21 studies who survived a median follow-up of 2.5 (range, 1.0-10.0) years, 30.9% (9974 of 32 268) became prefrail, with the pooled incidence rate being 150.6 (95% CI, 123.3-184.1; I2 = 98.9%) cases per 1000 person-years. The frailty and prefrailty incidence rates were significantly higher in women than men (frailty: 44.8 [95% CI, 36.7-61.3; I2 = 97.9%] vs 24.3 [95% CI, 19.6-30.1; I2 = 8.94%] cases per 1000 person-years; prefrailty: 173.2 [95% CI, 87.9-341.2; I2 = 99.1%] vs 129.0 [95% CI, 73.8-225.0; I2 = 98.5%] cases per 1000 person-years). The incidence rates varied by diagnostic criteria and country income level. The frailty and prefrailty incidence rates were significantly reduced when accounting for the risk of death.
Results of this study suggest that community-dwelling older adults are prone to developing frailty. Increased awareness of the factors that confer high risk of frailty in this population subgroup is vital to inform the design of interventions to prevent frailty and to minimize its consequences.
衰弱是一种重要的老年综合征,具有显著的公共卫生意义,但对于人群层面衰弱发展的风险,人们的了解有限。
估计社区居住的 60 岁及以上成年人中衰弱和衰弱前期的全球发生率。
从研究开始到 2019 年 1 月,通过使用“衰弱”“老年人”和“发生率”等关键词的组合,在 MEDLINE、Embase、PsycINFO、Web of Science、CINAHL Plus 和 AMED(补充和替代医学数据库)中进行了无语言限制的检索。对合格研究的参考文献进行了手工检索。
在系统评价中,两名作者进行了搜索、文章筛选和研究选择。有社区居住的 60 岁及以上成年人在基线时报告或有足够数据计算衰弱或衰弱前期发生率的队列研究符合入选标准。
使用 Joanna Briggs 研究所的《流行率和发生率研究的关键评估清单》评估纳入研究的方法学质量。使用随机效应(DerSimonian 和 Laird)模型进行荟萃分析。
在特定时间段内,新出现的衰弱(定义为健壮或衰弱前期个体中出现的新衰弱病例)和衰弱前期(定义为健壮个体中出现的新衰弱前期病例)的发生率。
在检索到的 15176 条参考文献中,有 46 项观察性研究纳入了来自 28 个国家的 120805 名非衰弱(健壮或衰弱前期)参与者,这些参与者在中位随访 3.0(范围 1.0-11.7)年后,有 13.6%(13678/100313)的人变得衰弱,其累积发病率为 43.4(95%CI,37.3-50.4;I2=98.5%)/1000 人年。衰弱前期个体的衰弱发生率明显高于健壮个体(累积发病率分别为 62.7[95%CI,49.2-79.8;I2=97.8%]和 12.0[95%CI,8.2-17.5;I2=94.9%]/1000 人年,差异有统计学意义(P<0.001)。在 21 项研究中,中位随访时间为 2.5(范围 1.0-10.0)年的健壮个体中,有 30.9%(9974/32268)的人成为衰弱前期,其累积发病率为 150.6(95%CI,123.3-184.1;I2=98.9%)/1000 人年。女性的衰弱和衰弱前期发生率明显高于男性(衰弱:44.8[95%CI,36.7-61.3;I2=97.9%]和 24.3[95%CI,19.6-30.1;I2=8.94%]/1000 人年;衰弱前期:173.2[95%CI,87.9-341.2;I2=99.1%]和 129.0[95%CI,73.8-225.0;I2=98.5%]/1000 人年)。诊断标准和国家收入水平的差异导致了发病率的不同。当考虑到死亡风险时,衰弱和衰弱前期的发生率显著降低。
本研究结果表明,社区居住的老年人易患衰弱。了解这一人群亚组中导致衰弱风险较高的因素,对于设计预防衰弱和最小化其后果的干预措施至关重要。